The semiconductor manufacturing equipment specialist reported record revenues in its fiscal 2024 fourth quarter.

Lyell Immunopharma (LYEL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...

L.B. Foster Company FSTR logged third-quarter 2024 earnings of $3.27 per share, up from the year-ago quarter's earnings of 5 ...

Coca-Cola (KO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.